---
title: "Yidu Tech Wins SGD 2.28 Million Dr Buddy Contract in Singapore Expansion Push"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285282293.md"
description: "Yidu Tech, Inc. has secured a SGD 2.28 million contract from Singapore Health Services Pte Ltd through its subsidiary EVYD Research Private Limited. This contract is part of Yidu Tech's expansion into Singapore, focusing on the Dr Buddy platform, which utilizes AI for clinical decision-making and precision healthcare. The project aims to enhance healthcare delivery efficiency and accuracy, while also fostering partnerships with various stakeholders in the healthcare sector. Yidu Tech specializes in AI-driven healthcare solutions, aiming to improve China's healthcare system."
datetime: "2026-05-05T23:28:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285282293.md)
  - [en](https://longbridge.com/en/news/285282293.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285282293.md)
---

# Yidu Tech Wins SGD 2.28 Million Dr Buddy Contract in Singapore Expansion Push

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Yidu Tech, Inc. ( (HK:2158) ) just unveiled an announcement.

Yidu Tech Inc. has announced that its subsidiary EVYD Research Private Limited has secured a contract worth about SGD 2.28 million from Singapore Health Services Pte Ltd to implement and provide support and maintenance for the Dr Buddy platform. The deal marks a significant milestone in Yidu Tech’s expansion into the Singapore market, reinforcing its regional ambitions and extending the reach of its AI-powered clinical decision and precision healthcare capabilities beyond its core base in China.

By deploying its AI that models real-world disease progression and simulates physicians’ clinical decision-making, Yidu Tech aims to enhance the efficiency and accuracy of care delivery while offering more affordable precision diagnostics and treatments. The project should strengthen the company’s position as a key enabler of data-driven healthcare in Asia, potentially deepening partnerships with hospitals, pharmaceutical firms, insurers and public health authorities seeking more resilient and inclusive digital health infrastructure.

**More about Yidu Tech, Inc.**

Yidu Tech Inc. is a healthcare technology company specializing in AI-driven solutions that support the intelligent upgrading of China’s healthcare system. Its products focus on intelligent decision-making across healthcare services, pharmaceuticals, insurance and patients, aiming to deliver precision diagnostics, treatment support and data-driven tools to clinicians, industry players and public health systems.

**Average Trading Volume:** 7,147,374

**Technical Sentiment Signal:** Buy

**Current Market Cap:** HK$6.39B

### Related Stocks

- [02158.HK](https://longbridge.com/en/quote/02158.HK.md)

## Related News & Research

- [Yidu Tech Wins RMB7.39 Million AI Clinical Research Platform Bid in Tianjin](https://longbridge.com/en/news/287157094.md)
- [Yidu Tech Wins RMB9 Million Smart Clinical Upgrade Project at Sun Yat-sen University Cancer Center](https://longbridge.com/en/news/285858466.md)
- [Is AI a bubble? It’s starting to get soapy](https://longbridge.com/en/news/286937439.md)
- [Palo Alto Networks CEO says AI won't mean fewer engineers: 'I need more'](https://longbridge.com/en/news/286949969.md)
- [Healthcare AI firm Commure valued at $7 billion, raises $70 million](https://longbridge.com/en/news/286936246.md)